Kumud Kalia - 01 Mar 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Signature
/s/ John Saia, as attorney-in-fact for Kalia Kumud
Issuer symbol
GH
Transactions as of
01 Mar 2023
Net transactions value
-$214,689
Form type
4
Filing time
03 Mar 2023, 15:59:33 UTC
Previous filing
09 Jan 2023
Next filing
05 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +711 +9.7% $0.000000 8,007 01 Mar 2023 Direct
transaction GH COMMON STOCK Tax liability $7,223 -246 -3.1% $29.36 7,761 01 Mar 2023 Direct F1
transaction GH COMMON STOCK Sale $207,466 -6,500 -84% $31.92 1,261 03 Mar 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -711 -9.1% $0.000000 7,102 01 Mar 2023 COMMON STOCK 711 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 Represents the weighted average price of shares sold at prices that ranged from $31.87 to $31.99.
F3 The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter.
F4 Not applicable for Restricted Stock Units.

Remarks:

Table I, includes 242 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2022.